| BMX |
IPI00514142 |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.845 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
0.845 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
0.845 |
Evidence |
|
| P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.845 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.845 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.845 |
Evidence |
|
| KCNJ1 |
KCNJ1, ROMK1: ATP-sensitive inward rectifier potassium channel 1 |
KCNJ12 |
KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 |
0.845 |
Evidence |
|
| FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
0.845 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.845 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.845 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.845 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.845 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.845 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
0.845 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.845 |
Evidence |
|
| FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.845 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.845 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.845 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.845 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
PRSS22 |
PRSS22, BSSP4, SP001LA, PRSS26, UNQ302/PRO343: Brain-specific serine protease 4 |
0.845 |
Evidence |
|
| BTC |
BTC: Probetacellulin precursor [Contains: Betacellulin |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.845 |
Evidence |
|
| MC4R |
MC4R: Melanocortin receptor 4 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
0.845 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
TRHR |
TRHR: Thyrotropin-releasing hormone receptor |
0.845 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
0.845 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.845 |
Evidence |
|